Femoral & Tibial Augment Block
by Joint Medical Products Corp.
510(k) K924940
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SN | NumberK924940 | Date9 Mar 1993 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JWH
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3560
- Advisory Committee
- Orthopedic
- FDA Decision
- SN
Overview
AI-generated summary, 1 Oct 2026
The Femoral & Tibial Augment Block is a modular orthopedic implant designed to augment bone defects in the femur and tibia during joint arthroplasty procedures. It consists of components intended to restore structural integrity and alignment in the knee joint, typically used in cases requiring additional support beyond standard prosthetic implants. The device is classified under orthopedic prostheses, featuring materials such as cobalt-chromium-molybdenum alloys and ultra-high molecular weight polyethylene for durability and biocompatibility.
This device is supplied as a reusable surgical implant and is intended for use in controlled operating room environments. It is regulated under the FDA’s 510(k) clearance (K924940) with a product code of JWH, adhering to 21 CFR 888.3560 standards. The augment block is engineered to provide cross-support without linkage across the joint, ensuring compatibility with existing knee arthroplasty systems. Storage and handling must comply with sterile surgical instrument protocols to maintain integrity before use.
Other devices from Joint Medical Products Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the Femoral & Tibial Augment Block used for?
The Femoral & Tibial Augment Block is designed to address bone defects in the femur or tibia during knee joint replacement surgeries. It provides additional structural support where standard prosthetic implants may not suffice, helping restore alignment and stability in the knee joint. This modular implant is particularly useful in cases requiring extra reinforcement beyond conventional arthroplasty components.
How is the Femoral & Tibial Augment Block supplied and prepared for use?
The device is supplied as a reusable surgical implant, intended for use in controlled operating room environments. It must be handled and stored according to sterile surgical instrument protocols to preserve its integrity before use. The cobalt-chromium-molybdenum alloy construction ensures durability, while ultra-high molecular weight polyethylene components maintain biocompatibility.
Is the Femoral & Tibial Augment Block single-use or reusable?
This augment block is explicitly designed for reuse within a sterile surgical setting. Its modular construction and robust materials—cobalt-chromium-molybdenum alloy and ultra-high molecular weight polyethylene—allow for repeated use under proper sterilization and handling procedures. Reusability is supported by FDA clearance under 510(k) K924940, provided adherence to sterile protocols is maintained.
What materials are used in the Femoral & Tibial Augment Block?
The augment block features cobalt-chromium-molybdenum alloys for its structural components, offering high strength and corrosion resistance. Ultra-high molecular weight polyethylene is incorporated for articulating surfaces, ensuring smooth motion and biocompatibility. These materials are selected for their durability, longevity, and compatibility with the human body in orthopedic applications.
How should the Femoral & Tibial Augment Block be stored?
Storage must comply with standard sterile surgical instrument protocols to prevent contamination or damage. The device should be kept in a clean, dry environment, protected from physical stress or exposure to chemicals. Since it is reusable, it must undergo proper sterilization between uses, adhering to FDA guidelines for orthopedic implants under 21 CFR 888.3560. Always follow manufacturer instructions for packaging and storage to maintain sterility and functionality.